Quote:
Originally Posted by 'Hamas' Jenkins
In reality, what am I going to gain as a pharmaceutical company spending hundreds of millions of dollars on a vaccine for a virus that causes maybe 1% of the colds in the human population, a virus which, at its worst, is going to lead to two weeks of discomfort but no real morbidity or mortality?
There are more serious viruses like RSV, which are like a ramped up cold, that can be serious or lethal to children, for which we have developed effective, but expensive treatments.
|
My first son had RSV at 3 weeks it was crazy how his sats would just drop like a rock from 98 to low 40 s then back up we were close to intubation and being chopperd to sick kids.